DPHARMA

Quarterly rpt on consolidated results for the financial period ended 31 Dec 2018

CCM DUOPHARMA BIOTECH BERHAD

Financial Year End 31 Dec 2018
Quarter 4 Qtr
Quarterly report for the financial period ended 31 Dec 2018
The figures have not been audited

Attachments

CCMDBIO-Q4 2018.pdf
250.5 kB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
31 Dec 2018

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31 Dec 2018
31 Dec 2017
31 Dec 2018
31 Dec 2017
$$'000
$$'000
$$'000
$$'000
1 Revenue
115,634
112,253
498,722
467,987
2 Profit/(loss) before tax
17,658
12,801
59,666
51,772
3 Profit/(loss) for the period
14,369
12,131
47,641
42,463
4 Profit/(loss) attributable to ordinary equity holders of the parent
14,369
12,131
47,641
42,463
5 Basic earnings/(loss) per share (Subunit)
2.17
1.86
7.26
6.52
6 Proposed/Declared dividend per share (Subunit)
4.00
2.57
5.50
3.64


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
 Net assets per share attributable to ordinary equity holders of the parent ($$)
0.7300
0.7400

Remarks : 
Pursuant to MFRS 133 Earnings Per Share, the Basic Earnings Per Share, Dividend Per Share and Net Assets Per Share for the corresponding quarter and year to date 31 December 2017 had been retrospectively adjusted to reflect the effect of the bonus issue.

Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

Country Base Unit Subunit
Malaysia Ringgit Sen
United States Dollar Cent
United Kingdom Pound Pence



Announcement Info

Company Name CCM DUOPHARMA BIOTECH BERHAD
Stock Name CCMDBIO
Date Announced 18 Feb 2019
Category Financial Results
Reference Number FRA-11022019-00012


View original report